Syros Pharmaceuticals (NASDAQ:SYRS) Posts Earnings Results, Beats Expectations By $0 10 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report)‘s stock had its “overweight” rating reiterated by Piper Sandler in a research note issued on Wednesday, Benzinga reports. They presently have a $13.00 price objective on the stock. Piper Sandler’s price target indicates a potential upside of 166.94% from the stock’s current price. Other analysts have also recently […]
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. Syros Pharmaceuticals Price Performance Shares of NASDAQ SYRS traded down $0.10 during mid-day trading on Tuesday, reaching $6.46. The company had a […]
Brookline Capital Management Weighs in on Syros Pharmaceuticals, Inc s Q2 2024 Earnings (NASDAQ:SYRS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals (SYRS) Set to Announce Quarterly Earnings on Tuesday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.